Chen et al. included 217 BC patients and finally constructed four radiomic models, and the XGBoost model outperformed other models in discriminating between HER2-over-expression and HER2-negative with an AUC of 0.72 in the test set [16]. Here, ERBB2 is linked to breast cancer.